2023-08-11 16:16:04 ET
- Entera Bio press release ( NASDAQ: ENTX ): 1H GAAP EPS of $0.16.
- As of June 30, 2023, Entera had cash and cash equivalents of $9.1 million. The Company expects that its existing cash resources are sufficient to meet its projected operating requirements into the third quarter of 2024, which includes the capital required to fund our ongoing operations, including R&D and the completion of the Phase 1B PK study related to our new generation platform and potential new formulations for EB612.
For further details see:
Entera Bio GAAP EPS of $0.16